- Digestive diseases
- Department of gynaecology
Founded in 2012, Jilin Deshang Pharmaceutical Co., Ltd. (hereinafter referred to as "Deshang Pharm") features a national high-tech pharmaceutical enterprise that integrates drug R&D, production and sales. Deshang Pharm owns two wholly-owned subsidiaries, namely Jilin Detai Pharmaceutical Co., Ltd. and Beijing Mega Pharmaceutical Science and Technology Co., Ltd. (National High-tech Enterprise).
Deshang is committed to providing patients with high-quality and low-cost products. Our products cover the fields of digestion, liver disease, Urology, endocrinology, gynecology, pediatrics, orthopedics and so on.
In the future, German merchants will focus on the R & D of products in the fields of digestion, liver and gallbladder, cardio cerebrovascular and mineral supplement.
Deshang pharmaceutical has professional R & D and registration strength, highly focused treatment field, efficient marketing system and outstanding experience in global BD cooperation.
Beijing Mega Pharmaceutical Science and Technology Co., Ltd., a wholly-owned subsidiary of the R&D Center of Deshang Pharm, is credited as a National High-tech Enterprise, Zhongguancun High-tech Enterprise, Beijing Patent Pilot Unit and Beijing Municipal Enterprise Science and Technology R&D Institution. The company is known for a professional R&D team, comprehensive R&D system and highlighted registration strength.
Deshang Pharm runs a Marketing Center to build a one-stop sales service platform for its partners. The Marketing Center falls into Commerce Department, Marketing Department, BD Department, Sales Service Department, Sales Finance Department and other departments. These departments adhere to an operation mechanism of efficient cooperation, which allows partners to enjoy a one-stop business and academic service system and top class service experience from the initial stage to all-round cooperation.
So far, Jilin Deshang has achieved close cooperation with domestic renowned enterprises such as Jilin Aodong Pharmaceutical Group Co., Ltd., Livzon Group and Shanghai Pharma Group, as well as some counterparts in Europe, America and southeast Asia.
Jilin Deshang's product series focus on digestive system, cardiovascular and cerebrovascular treatment, children's treatment and the healthcare industry. A huge demand for specialized drugs exists in the field of treatment, and there is huge market potential and profit margin of Deshang's products that are currently for sale and under research.
Jilin Deshang is home to a highly international BD (cooperation and development) team, most members are highly experienced in foreign pharmaceutical field and have multinational product introduction experience. Deshang is in search of high-tech patent innovative drugs globally, and actively bring them into the Chinese market.